| 1 |
MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement.Am J Surg Pathol. 2012 Oct;36(10):1444-51. doi: 10.1097/PAS.0b013e3182562bf8.
|
| 2 |
Recombinant granulocyte colony-stimulating factor (rG-CSF) in the management of neutropenia induced by anthracyclines and ifosfamide in patients with soft tissue sarcomas (NEUSAR).Support Care Cancer. 2017 Jan;25(1):111-117. doi: 10.1007/s00520-016-3390-0. Epub 2016 Aug 27.
|
| 3 |
A clinicopathologic study of head and neck rhabdomyosarcomas showing FOXO1 fusion-positive alveolar and MYOD1-mutant sclerosing are associated with unfavorable outcome.Oral Oncol. 2016 Oct;61:89-97. doi: 10.1016/j.oraloncology.2016.08.017. Epub 2016 Sep 6.
|
| 4 |
Mutation assay of the novel gene DOG1 in gastrointestinal stromal tumors (GISTs).J Gastroenterol. 2008;43(7):531-7. doi: 10.1007/s00535-008-2195-4. Epub 2008 Jul 23.
|
| 5 |
MAGEA4 expression in bone and soft tissue tumors: its utility as a target for immunotherapy and diagnostic marker combined with NY-ESO-1.Virchows Arch. 2017 Sep;471(3):383-392. doi: 10.1007/s00428-017-2206-z. Epub 2017 Jul 26.
|
| 6 |
Novel NTRK3 Fusions in Fibrosarcomas of Adults.Am J Surg Pathol. 2019 Apr;43(4):523-530. doi: 10.1097/PAS.0000000000001194.
|
| 7 |
Identification of a yeast artificial chromosome (YAC) spanning the synovial sarcoma-specific t(X;18)(p11.2;q11.2) breakpoint.Genes Chromosomes Cancer. 1993 Mar;6(3):182-9. doi: 10.1002/gcc.2870060309.
|
| 8 |
New advances in the molecular classification of pediatric mesenchymal tumors.Genes Chromosomes Cancer. 2019 Feb;58(2):100-110. doi: 10.1002/gcc.22681. Epub 2018 Oct 11.
|
| 9 |
Diagnosis of known sarcoma fusions and novel fusion partners by targeted RNA sequencing with identification of a recurrent ACTB-FOSB fusion in pseudomyogenic hemangioendothelioma.Mod Pathol. 2019 May;32(5):609-620. doi: 10.1038/s41379-018-0175-7. Epub 2018 Nov 21.
|
| 10 |
Immunohistochemical and molecular genetic approaches to soft tissue tumor diagnosis: a primer.Semin Oncol. 1997 Oct;24(5):515-25.
|
| 11 |
Detection of the ASPSCR1-TFE3 gene fusion in paraffin-embedded alveolar soft part sarcomas.Histopathology. 2007 Jun;50(7):881-6. doi: 10.1111/j.1365-2559.2007.02693.x.
|
| 12 |
Recurrent SRF-RELA Fusions Define a Novel Subset of Cellular Myofibroma/Myopericytoma: A Potential Diagnostic Pitfall With Sarcomas With Myogenic Differentiation.Am J Surg Pathol. 2017 May;41(5):677-684. doi: 10.1097/PAS.0000000000000811.
|
| 13 |
Distinct transcriptional signature and immunoprofile of CIC-DUX4 fusion-positive round cell tumors compared to EWSR1-rearranged Ewing sarcomas: further evidence toward distinct pathologic entities.Genes Chromosomes Cancer. 2014 Jul;53(7):622-33. doi: 10.1002/gcc.22172. Epub 2014 Apr 10.
|
| 14 |
Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases.Mod Pathol. 2002 Sep;15(9):931-8. doi: 10.1097/01.MP.0000026615.04130.1F.
|
| 15 |
Molecular detection of FUS-CREB3L2 fusion transcripts in low-grade fibromyxoid sarcoma using formalin-fixed, paraffin-embedded tissue specimens.Am J Surg Pathol. 2006 Sep;30(9):1077-84. doi: 10.1097/01.pas.0000209830.24230.1f.
|
| 16 |
Expression of dentin matrix protein 1 in tumors causing oncogenic osteomalacia.Mod Pathol. 2004 May;17(5):573-8. doi: 10.1038/modpathol.3800084.
|
| 17 |
What is new in epithelioid soft tissue tumors?.Virchows Arch. 2020 Jan;476(1):81-96. doi: 10.1007/s00428-019-02677-8. Epub 2019 Nov 4.
|
| 18 |
Identification of characteristic IGF2BP expression patterns in distinct B-ALL entities.Blood Cells Mol Dis. 2011 Apr 15;46(4):321-6. doi: 10.1016/j.bcmd.2011.02.005. Epub 2011 Mar 17.
|
| 19 |
Genomic profiling of bone and soft tissue tumors with supernumerary ring chromosomes using tiling resolution bacterial artificial chromosome microarrays.Oncogene. 2006 Nov 9;25(53):7106-16. doi: 10.1038/sj.onc.1209693. Epub 2006 May 29.
|
| 20 |
EWSR1-NFATC2 Translocation-associated Sarcoma Clinicopathologic Findings in a Rare Aggressive Primary Bone or Soft Tissue Tumor.Am J Surg Pathol. 2019 Aug;43(8):1112-1122. doi: 10.1097/PAS.0000000000001260.
|
| 21 |
Evaluation of NKX2-2 expression in round cell sarcomas and other tumors with EWSR1 rearrangement: imperfect specificity for Ewing sarcoma.Mod Pathol. 2016 Apr;29(4):370-80. doi: 10.1038/modpathol.2016.31. Epub 2016 Feb 5.
|
| 22 |
Molecular cytogenetic characterization of rhabdomyosarcoma cell lines.Cancer Genet Cytogenet. 2004 Jan 1;148(1):35-43. doi: 10.1016/s0165-4608(03)00216-4.
|
| 23 |
PRDM10-rearranged Soft Tissue Tumor: A Clinicopathologic Study of 9 Cases.Am J Surg Pathol. 2019 Apr;43(4):504-513. doi: 10.1097/PAS.0000000000001207.
|
| 24 |
Consistent SMARCB1 homozygous deletions in epithelioid sarcoma and in a subset of myoepithelial carcinomas can be reliably detected by FISH in archival material.Genes Chromosomes Cancer. 2014 Jun;53(6):475-86. doi: 10.1002/gcc.22159. Epub 2014 Mar 3.
|
| 25 |
The synovial sarcoma translocation protein SYT-SSX2 recruits beta-catenin to the nucleus and associates with it in an active complex.Oncogene. 2006 Jun 22;25(26):3661-9. doi: 10.1038/sj.onc.1209413. Epub 2006 Feb 6.
|
| 26 |
TFG, a target of chromosome translocations in lymphoma and soft tissue tumors, fuses to GPR128 in healthy individuals.Haematologica. 2010 Jan;95(1):20-6. doi: 10.3324/haematol.2009.011536. Epub 2009 Oct 1.
|
| 27 |
Reappraisal of TLE-1 immunohistochemical staining and molecular detection of SS18-SSX fusion transcripts for synovial sarcoma.Pathol Int. 2013 Dec;63(12):573-80. doi: 10.1111/pin.12113.
|
| 28 |
Expression of two testis-specific genes, TSGA10 and SYCP3, in different cancers regarding to their pathological features.Cancer Detect Prev. 2007;31(4):296-302. doi: 10.1016/j.cdp.2007.05.002.
|
|
|
|
|
|
|
